Vantage Health's business model is structured around its localized partnerships in sub-Saharan Africa, on a country-by-country basis. This model is designed to roll out quickly across various African nations using the same partnership principles and approach.



Contact Info:
C/O Steven T Lowe Esq
11400 West Olympic Boulevard
Suite 640
Los Angeles, CA 90064-1567
Website: http://www.vantagehealthgroup.com
Phone:             (310) 477-5811      
Email: ceo@vantagehealth.co.za


It is our mission to:

Alleviate the burden of HIV/AIDS and other life-threatening diseases which affect the lives of Africans and by extension, erode the wealth of African nations.
Assist in achieving the WHO (World Health Organization) Millennium Goals in Africa.
Observe good corporate governance and to act ethically at all times.
Create substantial value for our shareholders.



The Supply of medicines for:

-Essential Healthcare. - Vitamins & Minerals, Ear, Nose and Throat Treatment, Headache Medicine etc.
-Infectious diseases. - HIV/AIDS, STD's, TB, Malaria etc.
-Non-communicable diseases. - Heart Disease, Stroke, Cancer, Asthma, Diabetes etc.

The Supply of medical consumables and equipment such as

Surgical gloves
Sutures
Syringes
Male and Female condoms
HIV Test Kits for instant diagnosis






Maternal Obstetric Units:

-Our Maternal Obstetric Units will be strategically placed close to existing child health centres and provide a clean, safe and normal birthing environment. Our clinics will be staffed by our advanced midwives, who have been trained to evaluate women who may need urgent tertiary care and transfer them expeditiously and safely. A safe clean birthing environment is desperately needed to reduce the high maternal and neonatal mortality rates in Africa and in addition, provide an ongoing clinical touch point from which to educate people about Sexual and Child Health
The Fight Against HIV/AIDS:

-It is one of Vantage Health's core goals to make a significant contribution on the African continent in the struggle against the spread of HIV/AIDS. Through the supply of state of the art, WHO (World Health Organization) approved Rapid HIV Test Kits, anti-retrovirals, ISO certified Male and Female condoms and treatment and counselling facilities, we aim to reduce the sociological and economic burden of HIV/AIDS on the continent.



-The World Health Organization has estimated that only 28% of those in need of treatment are getting it.
-Africa is estimated to be home to 67% of all people living with HIV and to 72% of all AIDS deaths in 2009!
-VNTH announced this afternoon that its 51% owned South African subsidiary, Moxisign (PTY) Ltd., is finalizing a pricing structure for a Supply Agreement with the universal pharma division of a major Johannesburg Stock Exchange listed retail group!
-VNTH CEO and President Dr. Lisa Ramakrishnan, noted: "It has always been our intention to have our Moxisign subsidiary focused on the South African private sector as an adjunct to its public sector efforts. In terms of volume potential, we had, as one of our main priorities, the goal of partnering with an established and significant South African retail entity."
-For more information on VNTH, visit their website at: www.vantagehealthgroup.com Always do your own research and consult with a financial professional.
-VNTH has been invited by the Ministry of Health for the Kingdom of Swaziland to plan the construction of a pharma manufacturing facility in that country!

Share Structure:
Market Value1 $25,211,000 a/o Aug 02, 2011
Shares Outstanding 74,150,000 a/o Feb 15, 2011
Float 14,150,000 a/o Feb 03, 2011
Authorized Shares 250,000,000 a/o Apr 21, 2010

Read All Press Release's Here: http://www.otcmarkets.com/stock/VNTH/news
Financial Results: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001497130&owner=exclude&count=40

Daily Chart ~